Results 241 to 250 of about 2,481,224 (301)
CSPG4 is identified as a high‐value, stemness‐associated target in HPV‐negative HNSCC. By implementing rational biophysical engineering, a humanized and charge‐optimized CAR is developed to overcome tonic signaling‐induced exhaustion. This strategy induces a profound transcriptomic shift toward a rejuvenated, stem‐like memory state, significantly ...
Xiang Xu +13 more
wiley +1 more source
Atomically accurate de novo design of antibodies with RFdiffusion. [PDF]
Bennett NR +31 more
europepmc +1 more source
Emissions of unintentionally produced persistent organic pollutants (UPOPs) and global warming are two major environmental challenges. But their governance has largely evolved in parallel, leaving the toxicity implications of climate‐driven industrial transitions poorly understood.
Yuxiang Sun +7 more
wiley +1 more source
Clinical and genetic insights into novel TP53 mutations in De Novo AML patients. [PDF]
Akram AM +10 more
europepmc +1 more source
ZBTB21 is a transcription factor that epigenetically suppresses pyroptosis and MHC‐I antigen presentation, enabling tumor immune evasion. Genetic ablation of ZBTB21 activates pyroptotic cell death and enhances antigen presentation, recruiting CD8+ T cells to overcome immune checkpoint blockade resistance.
Lei Zhao +12 more
wiley +1 more source
Germline de novo mutation rate of the highly heterozygous amphioxus genome. [PDF]
Xue J, Tao L, Cao J, Wu L, Li G, Li C.
europepmc +1 more source
Gim3 buffers and potentiates de novo mutations that affect fluconazole susceptibility in yeast. [PDF]
Tawfeeq MT +8 more
europepmc +1 more source
Author Correction: Complex de novo structural variants are an underestimated cause of rare disorders. [PDF]
Jung H +12 more
europepmc +1 more source

